Jodie Lynn Bookout, RN | |
1100 S Nickel St, Deming, NM 88030-6301 | |
(575) 546-2678 | |
(575) 544-0918 |
Full Name | Jodie Lynn Bookout |
---|---|
Gender | Female |
Speciality | Registered Nurse - School |
Location | 1100 S Nickel St, Deming, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578094116 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | R57019 (New Mexico) | Secondary |
163WS0200X | Registered Nurse - School | 345592 (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jodie Lynn Bookout, RN 1100 S Nickel St, Deming, NM 88030-6301 Ph: (575) 546-2678 | Jodie Lynn Bookout, RN 1100 S Nickel St, Deming, NM 88030-6301 Ph: (575) 546-2678 |
News Archive
Eyedrops administered to infants as part of routine outpatient retinopathy of prematurity (ROP) screening can have life-threatening consequences. A case report published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) describes cardiopulmonary arrest in a 27-week-old infant following administration of three sets of cyclopentolate 0.2%/phenylephrine 1% (Cyclomydril) eyedrops.
Progenics Pharmaceuticals, Inc. today announced that it plans to advance oral methylnaltrexone for the treatment of opioid-induced constipation (OIC) into late stage clinical development and will commence a phase 2b/3 clinical trial of a methylnaltrexone tablet in chronic-pain patients in the second half of 2010. Progenics also announced data from a clinical trial of this methylnaltrexone tablet.
The study led by Imperial College London found that flexibility, as well as density, in the bone nanostructure is an important factor in assessing how likely someone is to suffer fractures.
Amorfix Life Sciences and Epitomics, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Amorfix has identified several disease specific epitopes (DSEs) on misfolded proteins with their proprietary ProMIS(TM) computational platform discovery technology, which will be used by Epitomics to generate highly specific monoclonal antibodies (mAbs).
› Verified 3 days ago
Mary Jaime, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1001 S Diamond Ave, Deming, NM 88030 Phone: 575-546-8841 | |
Dolores Coronado, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 215 S Silver Ave, Deming, NM 88030 Phone: 505-546-2771 Fax: 505-546-9427 | |
Julio Cesar Fermin, PMHNP-BC Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 901 W Hickory St, Deming, NM 88030 Phone: 575-546-2174 | |
Margaret Kemp, BSN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1001 S Diamond Ave, Deming, NM 88030 Phone: 575-531-2710 | |
Mayra Srader, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1300 S Iron St, Deming, NM 88030 Phone: 575-546-3123 | |
Mr. Jose Sanchez Sosa, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 905 S 8th St Ste B, Deming, NM 88030 Phone: 575-543-7200 Fax: 575-544-4897 | |
Stevi Dominguez, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1321 E Poplar St, Deming, NM 88030 Phone: 575-546-5951 |